ADTX Q3 2025 Earnings Deep Losses and Lack of Revenue Continue as Stock Tumbles Over 45 NKTX Q1 2026 Earnings Narrowing Loss and Stable Stock Performance CMBT Q1 2026 Earnings EPS Surges Past Estimates as Operational Efficiency Drives Profitability PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline ENLV Q4 2025 Earnings Significant EPS Miss Amid Development Stage Costs SIGA Q1 2026 Earnings Net Loss Reported Amid No Revenue Stock Declines